Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Schedules Conference Call for Third Quarter and Year-to-Date 2015 Financial Results

PR Newswire October 27, 2015

ANI Pharmaceuticals Announces Launch of Oxycodone Hydrochloride Oral Solution

PR Newswire October 16, 2015

ANI Pharmaceuticals Appoints Peter A. Lankau to Its Board of Directors

PR Newswire October 13, 2015

ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program

PR Newswire October 5, 2015

ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million

PR Newswire September 21, 2015

ANI Pharmaceuticals and IDT Australia Enter Partnership to Commercialize US Generic Drug Products

PR Newswire August 12, 2015

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights

PR Newswire August 4, 2015

ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results

PR Newswire July 28, 2015

ANI Pharmaceuticals and Sofgen Announce FDA Approval of Nimodipine 30mg Capsules

PR Newswire July 27, 2015

ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million

PR Newswire July 13, 2015

ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL

PR Newswire June 2, 2015

ANI Pharmaceuticals Presents at the UBS Global Healthcare Conference

PR Newswire May 15, 2015

ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%

PR Newswire May 13, 2015

ANI Pharmaceuticals Reports First Quarter 2015 Financial Results

PR Newswire May 5, 2015

ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results

PR Newswire April 28, 2015

ANI Pharmaceuticals Presents At 14th Annual Needham Healthcare Conference

PR Newswire April 7, 2015

ANI Pharmaceuticals Announces the Launch of Etodolac 200mg Capsules

PR Newswire March 10, 2015

ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals

PR Newswire March 5, 2015

ANI Pharmaceuticals To Present At 27th Annual ROTH Conference

PR Newswire March 4, 2015

ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results

PR Newswire February 19, 2015